Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

NCT00621036 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped MyVax did not meet its primary endpoints

Conditions

Brain and Central Nervous System Tumors
Lymphoma
Lymphoproliferative Disorder
Small Intestine Cancer

Interventions

BIOLOGICAL: autologous immunoglobulin idiotype-KLH conjugate vaccine
BIOLOGICAL: sargramostim
DRUG: methotrexate
DRUG: thiotepa
RADIATION: radiation therapy

Sponsor

University of Texas Southwestern Medical Center